C07C 205/59
The carbon skeleton being further substituted by singly-bound oxygen atoms
Official title: the carbon skeleton being further substituted by singly-bound oxygen atoms
C07C205/59 (The carbon skeleton being further substituted by singly-bound oxygen atoms) appears on 180 US grants and 70 published applications in this corpus.
Search patents in C07C- Granted patents
- 180
- Published applications
- 70
- Assignees
- 92
- Inventors
- 346
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 6 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 3 | 0 |
| 1982 | 9 | 0 |
| 1983 | 7 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 7 | 0 |
| 1987 | 4 | 0 |
| 1988 | 6 | 0 |
| 1989 | 10 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 0 |
| 2002 | 1 | 2 |
| 2003 | 2 | 1 |
| 2004 | 2 | 5 |
| 2005 | 1 | 1 |
| 2006 | 3 | 3 |
| 2007 | 0 | 4 |
| 2008 | 1 | 3 |
| 2009 | 0 | 2 |
| 2010 | 5 | 7 |
| 2011 | 2 | 3 |
| 2012 | 5 | 4 |
| 2013 | 6 | 3 |
| 2014 | 4 | 3 |
| 2015 | 2 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 4 |
| 2018 | 3 | 1 |
| 2019 | 2 | 1 |
| 2020 | 2 | 1 |
| 2021 | 0 | 3 |
| 2022 | 3 | 3 |
| 2023 | 1 | 2 |
| 2024 | 2 | 5 |
| 2025 | 2 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Small molecules promoting sympathetic nerve regeneration8 Sep 2026US 12,729,177 B2Oregon Health & Science University
- Resist composition and pattern forming process13 Jan 2026US 12,523,932 B2Shin-Etsu Chemical Co., Ltd.
- Processes and intermediates for preparing MCL1 inhibitors9 Sep 2025US 12,410,146 B2Gilead Sciences, Inc.
- Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof2 Sep 2025US 12,403,116 B2Chinese Academy of Medical Sciences Institue of Medicinal Plant Development
- Trialkyne linking agents and methods of use20 Aug 2024US 12,065,458 B2Arrowhead Pharmaceuticals, Inc.
- Processes and intermediates for synthesising opicapone23 Jul 2026US 2026/0209167 A1
- Process for the preparation of a pde4 inhibitor11 Jun 2026US 2026/0159483 A1Chiesi Farmaceutici S.P. A.
- Processes and intermediates for preparing mcl1 inhibitors26 Feb 2026US 2026/0055068 A1Gilead Sciences, Inc.
- Fragrance and flavor compositions comprising benzene derivatives24 Jul 2025US 2025/0236810 A1
- Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof5 Jun 2025US 2025/0177342 A1Chinese Academy of Medical Sciences Institute of Medicinal Plant Development
Most cited
By later US patents
- Catechol diethers as selective PDE.sup.IV inhibitors71US 5,814,651 APfizer Inc. · 1998
- Lawn assay for compounds that affect enzyme activity or bind to target molecules65US 5,856,083 APharmacopeia, Inc. · 1999
- Herbicidal 4-trifluoromethyl-4-nitrodiphenyl ethers52US 4,093,446 ARohm and Haas Company · 1978
- Herbicidal 4-trifluoromethyl-4'nitrodiphenyl ethers45US 4,063,929 ARohm and Haas Company · 1977
- Certain 2-(2-substituted benzoyl)-1,3-cyclohexanediones42US 5,006,158 AICI Americas Inc. · 1991